Effective January 1, 2021, hospitals must comply with HHS’ new hospital price transparency rule that requires facilities to create and maintain a public list of their standard charges, including private […]
Read More
Join Medical Marketing Whiz and Walt Eckert of Blue & Co., as they discuss How Outsourcing Can Grow Your Practice. You’re going to learn: Learn when it is the right […]
Read More
On September 2, 2020, CMS released its final ruling. It is effective beginning October 1, 2020, for FY 2021. This means it will go in to effect the first day […]
Read More
340B covered entities have likely felt bombarded during the last few weeks with various letters from manufacturers, word of additional cuts in Medicare part B drug reimbursement for some hospitals, […]
Read More
Join Medical Marketing Whiz and Tom Skoog of Blue & Co., as they discuss Cybersecurity: 5 Action Steps to Protect Your Practice. A lack of focus on cybersecurity can be […]
Read More
AstraZeneca distributed letters recently that as of October 1, 2020, 340B pricing will be available only through “a single contract pharmacy for those covered entities that do not maintain their […]
Read More
Join Medical Marketing Whiz and David Sproule of Blue & Co., as they discuss Tips for Keeping & Increasing Cash Flow of Your Practice. You’re going to learn: What you […]
Read More
In 2018, the Center for Medicare & Medicaid Services (CMS) implemented a change in reimbursement for DSHs, RRCs, and non-rural SCHs for Medicare Part B drugs obtained through the 340B […]
Read More
A new issue is affecting some inpatient hospital and Skilled Nursing Facility (SNF) claims when an interrupted stay is billed at the end of the month. The system incorrectly assigns […]
Read More
The Health Resources and Services Administration has set the annual recertification of eligibility for 340B drug discounts for hospitals to begin August 17, 2020 and end September 14, 2020. Mandatory […]
Read More
Many Continuing Care Retirement Communities (CCRCs) and Life Plan Communities (LPCs) are facing complex and dynamic challenges. In addition to the significant pressure of supporting an aging baby boomer population, […]
Entity-owned pharmacies are an important consideration for hospitals, community health centers, and other 340B grantee types. As retail pharmacy closures rise and the complexities of the 340B Drug Discount Program […]
By Joel Barnett, Technical Account Executive at Blue Pioneer Consulting and Holly Fields, CPA, Senior Manager at Blue & Co. Not-for-profit organizations handle sensitive data every day, which make them […]
Copyright © 2025, Blue & Co., LLC.
All Rights Reserved.
